摘要
目的:讨论不同剂量米非司酮保守治疗子宫肌瘤的临床疗效。方法:选择80例保守治疗子宫肌瘤的患者,均使用米非司酮治疗,分为两组,使用每天每次25 mg的为实验组,使用每天每次10 mg为对照组。结果:两组的治疗效果,生活质量评分相比,差异较大(P<0.05)。两组的不良反应发生率以及E2,FSH,P水平相比,差异较小(P>0.05)。结论:在实行保守治疗的子宫肌瘤患者中使用每天每次25 mg剂量的米非司酮治疗,能够提高治疗效果,改善生活质量,与小剂量治疗相比,不会增加不良反应发生率以及E2,FSH,P水平,具有重要的临床价值。
Objective:To discuss the efficacy of different doses of mifepristone in the conservative treatment of uterine leiomyoma.Methods:80 cases of conservative treatment of uterine leiomyoma were treated with mifepristone,divided into two groups,per day as the experimental group and 10 mg per day as the control group.Results:The therapeutic effect and quality of life score of the two groups were significantly different(P<0.05).The incidence of adverse reactions and E2,FSH,P levels in the two groups were smaller(P>0.05).Conclusion:The use of 25 mg mifepristone per day in patients with uterine leiomyoma treated with conservative treatment can improve the therapeutic effect and quality of life.It does not increase the incidence of adverse reactions and E2,FSH,P levels,and has important clinical value.
作者
师建花
SHI Jian-hua(Minxian people's Hospital of Gansu Province,Dingxi Gansu 748400,China)
出处
《医学食疗与健康》
2021年第27期61-62,共2页
Medical Diet and Health
关键词
米非司酮
不同剂量
子宫肌瘤
保守治疗
Mifepristone
Different doses
Hysteromyoma
Conservative treatment
